Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6151
HighPeak Energy
HPK
$940M
| $18K | ﹤0.01% |
1,655
-144,306
| -99% | -$2.43M |
|
6152
Intellicheck
IDN
$56.9M
| $18K | ﹤0.01% |
7,583
+923
| +14% | +$2.23K |
|
|
IMA
6153
ImageneBio Inc
IMA
$66.3M
| $18K | ﹤0.01% |
220
+198
| +900% | +$14.2K |
|
6154
KLX Energy Services
KLXE
$35.3M
| $18K | ﹤0.01% |
1,887
-15,516
| -89% | -$153K |
|
|
KZR
6155
DELISTED
Kezar Life Sciences
KZR
| $18K | ﹤0.01% |
746
+447
| +149% | +$11.6K |
|
6156
Lexicon Pharmaceuticals
LXRX
$1.03B
| $18K | ﹤0.01% |
7,907
+3,247
| +70% | +$8.62K |
|
6157
Oak Valley Bancorp
OVLY
$287M
| $18K | ﹤0.01% |
702
+699
| +23,300% | +$17K |
|
6158
Spire Global
SPIR
$540M
| $18K | ﹤0.01% |
4,337
+2,378
| +121% | +$12.7K |
|
6159
AdvisorShares Insider Advantage ETF
SURE
$58.1M
| $18K | ﹤0.01% |
185
| – | – |
|
6160
ThredUp
TDUP
$403M
| $18K | ﹤0.01% |
7,297
+3,154
| +76% | +$8.26K |
|
6161
TELA Bio
TELA
$28.9M
| $18K | ﹤0.01% |
1,734
+1,456
| +524% | +$14.9K |
|
6162
Universal Electronics
UEIC
$67.9M
| $18K | ﹤0.01% |
1,943
-6,415
| -77% | -$59.4K |
|
|
ENFN
6163
DELISTED
Enfusion, Inc.
ENFN
| $18K | ﹤0.01% |
1,585
+66
| +4% | +$585 |
|
|
BCOV
6164
DELISTED
Brightcove, Inc.
BCOV
| $18K | ﹤0.01% |
4,532
+314
| +7% | +$1.27K |
|
|
LLAP
6165
DELISTED
Terran Orbital Corporation
LLAP
| $18K | ﹤0.01% |
11,629
+6,405
| +123% | +$10.1K |
|
6166
Annexon
ANNX
$867M
| $17K | ﹤0.01% |
4,773
+4,764
| +52,933% | +$20.8K |
|
6167
Cognyte Software
CGNT
$674M
| $17K | ﹤0.01% |
2,785
+327
| +13% | +$1.52K |
|
6168
Distribution Solutions Group
DSGR
$1.62B
| $17K | ﹤0.01% |
640
-392
| -38% | -$9.22K |
|
6169
Eton Pharmaceutcials
ETON
$1.61B
| $17K | ﹤0.01% |
4,881
+4,511
| +1,219% | +$16.6K |
|
6170
First Community Corp
FCCO
$323M
| $17K | ﹤0.01% |
+994
| New | +$18.3K |
|
6171
CapForce IBD 50 ETF
FFTY
$81.2M
| $17K | ﹤0.01% |
660
-25,544
| -97% | -$605K |
|
6172
Arrow Dow Jones Global Yield ETF
GYLD
$37.9M
| $17K | ﹤0.01% |
1,400
+200
| +17% | +$2.51K |
|
|
KORE
6173
DELISTED
KORE Group Holdings
KORE
| $17K | ﹤0.01% |
2,845
-552
| -16% | -$3.65K |
|
6174
Ramaco Resources Class B
METCB
$432M
| $17K | ﹤0.01% |
+1,749
| New | +$16.9K |
|
|
MPX
6175
DELISTED
Marine Products Corp
MPX
| $17K | ﹤0.01% |
1,021
+30
| +3% | +$443 |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.